Portnoy A, Campos NG, Sy S, et al. - Researchers used multiple modeling methods that captured human papillomavirus (HPV) transmission, cervical carcinogenesis, and population demographics to project health and economic outcomes correlated with HPV vaccination in order to analyze the cost-efficiency of the campaign contrasted with routine delivery approaches of growing female HPV vaccination in Uganda. They projected that compared with routine vaccination, campaign HPV vaccination would give substantial population health advantages. Moreover, depending on the attainable coverage level and campaign rate, developing the target age range of campaign vaccination up to age 30 years could be an effective approach.